Involvement of the disulfidptosis-related immune checkpoint gene, CD276, in glioblastoma malignant phenotype and poor prognosis
CD276 was the most significant hub gene involved in disulfidptosis and immune checkpoints in GBM. Anti-CD276 therapy may have promise for GBM treatment.
Authors
- Haitao Shen (ORCID: https://orcid.org/0009-0000-6276-9921)
- Meng Ji (ORCID: https://orcid.org/0000-0002-1277-2118)
- Yinong Xu (ORCID: https://orcid.org/0000-0002-9718-8323)
- Jianwei Zhuo
- Jing Zhang (ORCID: https://orcid.org/0000-0002-2488-5021)
- Gang Cui (ORCID: https://orcid.org/0000-0001-8870-5053)
Institutions
- Soochow University (CN)
- Taizhou Fourth People's Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Neurological Research
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1080/01616412.2025.2476506
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- Research and Development